R-268712

R-268712
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T16708-1mg 1 mg

7 - 10 business days*

40.00€
TGM-T16708-5mg 5 mg

7 - 10 business days*

88.00€
TGM-T16708-1mL 1 ml

7 - 10 business days*

98.00€
TGM-T16708-10mg 10 mg

7 - 10 business days*

139.00€
TGM-T16708-25mg 25 mg

7 - 10 business days*

276.00€
TGM-T16708-50mg 50 mg

7 - 10 business days*

419.00€
TGM-T16708-100mg 100 mg

7 - 10 business days*

596.00€
 
Description: R-268712 is a specific activin receptor-like kinase 5 (ALK5) inhibitor(IC50 of 2.5... more
Product information "R-268712"
Description: R-268712 is a specific activin receptor-like kinase 5 (ALK5) inhibitor(IC50 of 2.5 nM). It is also an orally active transforming growth factor-beta type I receptor inhibitor. Target: ALK, TGF-beta/Smad. Smiles: Cc1cccc(n1)-c1n[nH]cc1-c1ccc(F)c(c1)-c1cnn(CCO)c1. References: Terashima H, et al. R-268712, an orally active transforming growth factor-beta type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model. Eur J Pharmacol. 2014 Jul 5,734:60-6.
Supplier: TargetMol
Supplier-Nr: T16708

Properties

Application: TGF-beta receptor type-1 (ALK5) inhibitor
MW: 363.39 D
Formula: C20H18FN5O

Database Information

CAS : 879487-87-3| Matching products
KEGG ID : K04674 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "R-268712"
Write a review
or to review a product.
Viewed